CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Executive Officer sold 1,605 shares at $34.56 ($55,462)
- 4 Open-market sale See Remarks sold 398 shares at $32.88 ($13,085)
- 4 Open-market sale Chief Executive Officer sold 2,255 shares at $32.88 ($74,140)
- 4 Open-market sale SVP of Human Resources sold 877 shares at $32.88 ($28,834)
- 4 Open-market sale Chief Accounting Officer sold 230 shares at $32.88 ($7,562)
- 4 Open-market sale See Remarks sold 757 shares at $26.50 ($20,063)
- 4 Open-market sale President and COO sold 1,776 shares at $26.50 ($47,070)
- 4 Open-market sale SVP of Human Resources sold 598 shares at $26.50 ($15,849)
- 4 Open-market sale Chief Financial Officer sold 887 shares at $26.50 ($23,509)
- 4 Open-market sale Chief Executive Officer sold 2,663 shares at $26.50 ($70,579)
- 4 Open-market sale Chief Accounting Officer sold 1,051 shares at an average $28.23 ($29,669)
- 4 Grant or award Chief Executive Officer acquired 146,914 shares (grant or award)
- 4 Grant or award President and COO acquired 68,740 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 32,648 shares (grant or award)
- 4 Grant or award See Remarks acquired 25,465 shares (grant or award)
- 4 Grant or award SVP of Human Resources acquired 26,200 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 16,324 shares (grant or award)
- 4 Open-market sale Director sold 7,044 shares at $24.77 ($174,480)
- 4 Open-market sale See Remarks sold 1,019 shares at $32.08 ($32,689)
- 4 Open-market sale President and COO sold 2,755 shares at $32.08 ($88,379)
Page 7 of 51 · 1,011 filings